Published in J Am Coll Cardiol on July 05, 2016
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Cyclosporine before PCI in Patients with Acute Myocardial Infarction. N Engl J Med (2015) 5.90
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med (2005) 5.28
High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury. Circulation (2008) 2.47
Feasibility of diastolic function assessment with cardiac CT: feasibility study in comparison with tissue Doppler imaging. JACC Cardiovasc Imaging (2011) 2.18
Immunohistochemical characterisation of dendritic cells in human atherosclerotic lesions: possible pitfalls. Pathology (2011) 2.07
Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure. Circ Heart Fail (2010) 2.04
Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol (2010) 2.00
Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool? Chest (2005) 1.78
Case report: inadvertent intrathecal placement of a pulmonary artery catheter introducer. Anesth Analg (2012) 1.46
Position of Edwards SAPIEN transcatheter valve in the aortic root in relation with the coronary ostia: implications for percutaneous coronary interventions. Catheter Cardiovasc Interv (2014) 1.42
Deep vein thrombosis after transfemoral endomyocardial biopsy in cardiac transplant recipients. J Heart Lung Transplant (2003) 1.42
Pulmonary vascular response to exercise in symptomatic heart failure with reduced ejection fraction and pulmonary hypertension. Eur J Heart Fail (2014) 1.40
Usefulness of type D personality in predicting five-year cardiac events above and beyond concurrent symptoms of stress in patients with coronary heart disease. Am J Cardiol (2006) 1.28
Cytokines and immune activation in systolic heart failure: the role of Type D personality. Brain Behav Immun (2003) 1.25
Combined endurance-resistance training vs. endurance training in patients with chronic heart failure: a prospective randomized study. Eur Heart J (2008) 1.12
Predictive value of social inhibition and negative affectivity for cardiovascular events and mortality in patients with coronary artery disease: the type D personality construct. Psychosom Med (2013) 1.11
Importance of suitable reference gene selection for quantitative real-time PCR: special reference to mouse myocardial infarction studies. PLoS One (2011) 1.10
Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied. Thromb Res (2010) 1.09
Automatic assessment of stent neointimal coverage by intravascular optical coherence tomography. Eur Heart J Cardiovasc Imaging (2013) 1.06
Systemic inflammation and reperfusion injury in patients with acute myocardial infarction. Mediators Inflamm (2005) 1.04
Feasibility of tissue magnetic resonance imaging: a pilot study in comparison with tissue Doppler imaging and invasive measurement. J Am Coll Cardiol (2005) 1.02
Quantification of circulating endothelial progenitor cells: a methodological comparison of six flow cytometric approaches. J Immunol Methods (2008) 1.01
Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure. Int J Cardiol (2005) 1.00
Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway. Int J Cardiol (2010) 1.00
Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study. J Am Coll Cardiol (2002) 0.99
Quantification of circulating CD34+/KDR+/CD45dim endothelial progenitor cells: analytical considerations. Int J Cardiol (2012) 0.99
A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile. J Appl Physiol (1985) (2008) 0.97
Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure. Eur Heart J (2004) 0.97
Exercise training improves function of circulating angiogenic cells in patients with chronic heart failure. Basic Res Cardiol (2010) 0.96
Effect of folic acid on endothelial function following acute myocardial infarction. Am J Cardiol (2006) 0.96
Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease. Coron Artery Dis (2006) 0.96
Exercise acutely reverses dysfunction of circulating angiogenic cells in chronic heart failure. Eur Heart J (2010) 0.96
Comparing Type D personality and older age as correlates of tumor necrosis factor-alpha dysregulation in chronic heart failure. Brain Behav Immun (2008) 0.95
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease. Am J Physiol Heart Circ Physiol (2008) 0.95
Proteasome inhibitor bortezomib promotes a rupture-prone plaque phenotype in ApoE-deficient mice. Basic Res Cardiol (2009) 0.94
STEMI mortality in community hospitals versus PCI-capable hospitals: results from a nationwide STEMI network programme. Eur Heart J Acute Cardiovasc Care (2012) 0.93
Colour M-mode velocity propagation: a glance at intra-ventricular pressure gradients and early diastolic ventricular performance. Eur J Heart Fail (2005) 0.90
Multimodal in vivo imaging reveals limited allograft survival, intrapulmonary cell trapping and minimal evidence for ischemia-directed BMSC homing. BMC Biotechnol (2012) 0.89
Impaired fibrillin-1 function promotes features of plaque instability in apolipoprotein E-deficient mice. Circulation (2009) 0.89
Immunohistostaining assays for detection of Chlamydia pneumoniae in atherosclerotic arteries indicate cross-reactions with nonchlamydial plaque constituents. J Clin Microbiol (2004) 0.89
Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload. Acta Cardiol (2015) 0.89
Anger, suppressed anger, and risk of adverse events in patients with coronary artery disease. Am J Cardiol (2010) 0.89
Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarction. Arch Intern Med (2011) 0.88
Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis. Eur J Heart Fail (2014) 0.87
Human C-reactive protein activates monocyte-derived dendritic cells and induces dendritic cell-mediated T-cell activation. Arterioscler Thromb Vasc Biol (2008) 0.87
Exercise training reverses adiponectin resistance in skeletal muscle of patients with chronic heart failure. Heart (2011) 0.87
Unraveling new mechanisms of exercise intolerance in chronic heart failure: role of exercise training. Heart Fail Rev (2013) 0.86
Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaques. Mediators Inflamm (2011) 0.86
Gender, TIMI risk score and in-hospital mortality in STEMI patients undergoing primary PCI: results from the Belgian STEMI registry. EuroIntervention (2014) 0.86
Safety and efficacy of the cobalt chromium PRO-Kinetik coronary stent system: results of the MULTIBENE study. Cardiovasc Revasc Med (2012) 0.86
Decreased numbers of peripheral blood dendritic cells in patients with coronary artery disease are associated with diminished plasma Flt3 ligand levels and impaired plasmacytoid dendritic cell function. Clin Sci (Lond) (2011) 0.85
Chronic heart failure: an example of a systemic chronic inflammatory disease resulting in cachexia. Int J Cardiol (2002) 0.85
Intracellular monocyte cytokine production and CD 14 expression are up-regulated in severe vs mild chronic heart failure. J Heart Lung Transplant (2005) 0.84
Comparison of magnetic resonance imaging of aortic valve stenosis and aortic root to multimodality imaging for selection of transcatheter aortic valve implantation candidates. Am J Cardiol (2011) 0.84
Changes in blood dendritic cell counts in relation to type of coronary artery disease and brachial endothelial cell function. Coron Artery Dis (2010) 0.84
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2015) 0.84
Depressed expression of MuRF1 and MAFbx in areas remote of recent myocardial infarction: a mechanism contributing to myocardial remodeling? Basic Res Cardiol (2009) 0.84
Selective intestinal decontamination in advanced chronic heart failure: a pilot trial. Eur J Heart Fail (2004) 0.83
Cost-effectiveness of contemporary vascular closure devices for the prevention of vascular complications after percutaneous coronary interventions in an all-comers PCI population. EuroIntervention (2014) 0.83
Prevalence, associated factors and management implications of left ventricular outflow tract obstruction in takotsubo cardiomyopathy: a two-year, two-center experience. BMC Cardiovasc Disord (2014) 0.83
Multi-slice computed tomography with N1177 identifies ruptured atherosclerotic plaques in rabbits. Basic Res Cardiol (2009) 0.83
Reperfusion therapy and mortality in octogenarian STEMI patients: results from the Belgian STEMI registry. Clin Res Cardiol (2013) 0.83
Unfavorable outcome of heart transplantation in recipients with type D personality. J Heart Lung Transplant (2007) 0.82
Exercise training reduces circulating adiponectin levels in patients with chronic heart failure. Clin Sci (Lond) (2010) 0.82
Association between left ventricular global longitudinal strain and adverse left ventricular dilatation after ST-segment-elevation myocardial infarction. Circ Cardiovasc Imaging (2013) 0.82
β-blockers modify the prognostic value of adiponectin in chronic heart failure. Int J Cardiol (2010) 0.82
Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions. Am J Cardiol (2013) 0.81
Assessment of endothelial dysfunction in childhood obesity and clinical use. Oxid Med Cell Longev (2013) 0.81
Circulating CD34+/KDR+ endothelial progenitor cells are reduced in chronic heart failure patients as a function of Type D personality. Clin Sci (Lond) (2009) 0.81
Methodological considerations and practical recommendations for the application of peripheral arterial tonometry in children and adolescents. Int J Cardiol (2013) 0.81
Endothelial microparticles (EMP) for the assessment of endothelial function: an in vitro and in vivo study on possible interference of plasma lipids. PLoS One (2012) 0.81
The effect of acute exercise on endothelial progenitor cells is attenuated in chronic heart failure. Eur J Appl Physiol (2011) 0.81
Inter-hospital variation in length of hospital stay after ST-elevation myocardial infarction: results from the Belgian STEMI registry. Acta Cardiol (2013) 0.81
Chlamydia pneumoniae-based atherosclerosis: a smoking gun. Acta Cardiol (2007) 0.81
Quantitative coronary arteriography on digital flat-panel system. Catheter Cardiovasc Interv (2004) 0.81
Endothelium dependent vasomotion and in vitro markers of endothelial repair in patients with severe sepsis: an observational study. PLoS One (2013) 0.80
Coronary spasm after the topical use of cocaine in nasal surgery. Am J Case Rep (2013) 0.80
Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood. J Immunol Methods (2010) 0.79
Stereology: a simplified and more time-efficient method than planimetry for the quantitative analysis of vascular structures in different models of intimal thickening. Cardiovasc Pathol (2007) 0.79
B-type natriuretic peptide and assessment of jeopardised myocardium in acute myocardial infarction. Int J Cardiol (2006) 0.79
Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP. Am Heart J (2010) 0.79